Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

NCT01872026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy
Pharmacodynamics of ASP7991
Pharmacokinetics of ASP7991

Interventions

DRUG: ASP7991

Sponsor

Astellas Pharma Inc